Background {#Sec1}
==========

As the proportion of older patients admitted to critical care rises \[[@CR1], [@CR2]\], there is a pressing need to understand how critical care might best support a population with potentially complex medical, physical and psychosocial concerns. Only recently have studies started to explore the relevance of frailty assessment to the care of critically ill adults \[[@CR3], [@CR4]\]. Related to, though distinct from, co-morbidity and disability, frailty is a term used to describe \"a condition characterised by loss of biological reserve and vulnerability to poor resolution of homeostasis following a stressor event\" \[[@CR5]\]. Frailty implies an impaired ability to withstand the physiological disturbance of an acute illness, and although it becomes more prevalent with age it is not exclusive to an older population.

A range of methods to evaluate frailty are described in the literature \[[@CR5]--[@CR8]\], with the utility of a particular frailty assessment tool dependent on the purpose, setting, time available, and skill of the assessor \[[@CR9]\]. For the acutely ill, assessment tools might best be described as one of: a judgment-based measure (e.g. the clinical frailty scale (CFS) \[[@CR10]\]); a single physical performance measure (e.g. grip strength); a frailty phenotype (depending on the presence of typically three to five criteria \[[@CR11]\]); an extended multidimensional assessment (e.g. Tilburg Frailty Indicator \[[@CR12], [@CR13]\]); and a frailty index, the number of accumulated deficits associated with adverse outcome presented as a proportion with respect to the total number (30 or more) of pre-specified possible deficits \[[@CR14]\].

Previous systematic reviews have examined the psychometric properties of frailty assessment tools in primarily non-acute settings \[[@CR6]--[@CR8], [@CR15]\]. However, the validity and reliability of an assessment tool is largely dependent on the setting and population in which it was developed and validated \[[@CR8]\], and frailty assessment in the critically ill poses particular challenges. At the outset of critical illness, there is often a reliance on proxy respondents \[[@CR4]\]. Furthermore, frailty is itself an independent risk factor for delirium, can coexist with dementia and is associated with disability \[[@CR5]\]. Proxy ratings do not necessarily correspond with a subject\'s own assessment of function or quality of life during the recovery from critical illness \[[@CR16]--[@CR19]\]. Last, there is inherent risk of inadvertently ascribing features of acute illness to underlying frailty \[[@CR20]\] and of recall bias with retrospective inquiry. Given these concerns, we aimed to systematically review the literature to establish the feasibility and reliability of frailty assessment in the critically ill.

Methods {#Sec2}
=======

Our review was performed according to recommendations for the systematic review of observational studies \[[@CR21]\] and was registered prospectively via PROSPERO (PROSPERO, <https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=52073>) with registration number: CRD42016052073.

Eligibility criteria {#Sec3}
--------------------

The inclusion criteria were:The study included adult (16 years and over) patients being managed in a critical care environment.The study involved the application of a multidimensional frailty assessment tool.The study presented data relating to the feasibility of frailty assessment in the critically ill (timing of evaluation, the background, training and expertise required for assessors, and reliance upon proxy input), and/or of the reliability of frailty assessment in the critically ill.

Reviews, case reports and case series were excluded; studies that collected data retrospectively were not excluded, but the potential bias associated with retrospective as opposed to prospective study was considered. Data from the control arm of randomised controlled trials (RCTs) were considered for inclusion if the trial eligibility criteria identified a study population that was representative of the general critical care population. Studies were limited to English language publications from 2001 onwards. However, there was no restriction on the basis of publication status, provided eligibility criteria were otherwise met.

Information sources {#Sec4}
-------------------

We searched the following databases from January 2001 to October 2017: Medline, Medline In-process, EMBASE, CINAHL, PsycINFO, AMED, Cochrane Database of Systematic Reviews, and Web of Science. Additional studies were sought from grey literature using the Open Grey database and by screening critical care conference abstracts, from the reference lists of papers and review articles, and through searches for full-text publication of relevant abstracts.

Data management {#Sec5}
---------------

Two authors independently screened titles and abstracts. An additional author also contributed to hand-searching reference lists of identified papers and review articles. A spreadsheet was used to keep a log of all potentially relevant studies and reasons for inclusion or exclusion. In the event of disagreement following full-text review, consensus was achieved through discussion without recourse to a third author. Data from included studies were extracted using a standardised data collection proforma and additional information sought from trial authors where appropriate.

Data items {#Sec6}
----------

Study data extraction included: author, year, publication type, country, methodology and setting. Relevant patient characteristics of studied cohorts included: demographic data (age, gender), presence of co-morbidity, evidence of baseline level of dependence, primary reason for admission, surgical status, and severity of illness (according to established illness severity scales). Timing of frailty assessment was recorded (e.g. with reference to a point in time before the acute illness, at time of referral, at time of admission to critical care, or during recovery from acute illness), and interval between assessments. Information on the participation of the patient in the frailty assessment process was collected, as was the background of the individual(s) making the assessment of frailty.

Outcomes and prioritisation {#Sec7}
---------------------------

Feasibility of the frailty measurement tools in critical care was assessed on the basis of time taken to perform the assessment, training, and expertise required to implement, the proportion of potentially eligible patients excluded, and reasons for exclusion (e.g. due to lack of proxy).

Given that frailty state is not static in the context of an acute illness \[[@CR4], [@CR22]\], in assessing reliability our primary interest was the contemporaneous measure of inter-rater reliability. Where available, for ordinal scores we extracted the linear weighted kappa in line with consensus-based standards \[[@CR23]\].

Risk of bias for individual studies {#Sec8}
-----------------------------------

We did not identify any eligible RCTs, but for observational studies the risk of bias was assessed using the Newcastle-Ottawa checklist \[[@CR24]\] according to the domains of selection, comparability, exposure, and outcome. For each domain, a judgement of low, unclear, or high risk of bias was made. Studies were considered as at overall low risk of bias if all domains were judged as low risk; studies were considered high risk if any domains were deemed high risk. Depending on number and risk of studies identified, it was intended that sensitivity analysis might be performed excluding high-risk studies.

Results {#Sec9}
=======

Study selection {#Sec10}
---------------

Search results are summarised in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) \[[@CR25]\] diagram (Fig. [1](#Fig1){ref-type="fig"}). There were 2180 articles identified, of which 69 were considered potentially eligible. Following full-text review, a total of 11 study publications were included \[[@CR26]--[@CR36]\], representing 8 study cohorts and a total of 7761 patients.Fig. 1Flow diagram of included studies \[[@CR25]\]

Study characteristics {#Sec11}
---------------------

The characteristics of included studies are summarised in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. Two research groups presented separate analyses of study cohorts in multiple publications (Bagshaw \[[@CR26]--[@CR28]\] and Heyland \[[@CR33], [@CR34]\]) but for the purposes of this review each study cohort was considered as a single study. Four studies were conducted in North America \[[@CR26]--[@CR29], [@CR33]--[@CR35]\], three in Europe (including one large study involving 21 countries) \[[@CR30], [@CR31], [@CR36]\] and one in Australia \[[@CR32]\]. The majority of studies were multi-centre \[[@CR26]--[@CR30], [@CR33]--[@CR36]\] and set in mixed medical-surgical ICUs. The median sample size was 385 patients (range 30--5021). Four of the studies adopted age restrictions: age 50 years or more \[[@CR26]--[@CR28]\], 65 years or more \[[@CR30]\], and 80 years or more \[[@CR33], [@CR34], [@CR36]\]. Only one study explicitly excluded patients with severe cognitive disease, including dementia \[[@CR29]\]. The majority of patients were male, and 61% received invasive ventilation.Table 1Study characteristicsStudyYearFull textCountry/countriesNumber of sitesSettingIntended study outcomesAdditional data provided by study authors?Bagshaw \[[@CR26]--[@CR28]\]2014, 2015, 2016YesCanada6Mixed medical-surgical ICUPredictive validity: in-hospital mortality, health-related quality of life-Brummel \[[@CR29]\]2017YesUSA5Medical and surgical ICUPredictive validity: mortality, disability, cognitive impairmentYesFisher \[[@CR32]\]2015YesAustralia1Mixed-medical surgical ICUPredictive validity: mortality, length of stay, discharge destination Feasibility-Flaatten \[[@CR36]\]2017YesEurope (21 countries)311Mixed ICUsPredictive validity: mortalityYesHeyland \[[@CR33], [@CR34]\]2015, 2015YesCanada22Mixed ICUsPredictive validity: prolonged dying experience, physical recovery at 12 monthsYesHope \[[@CR35]\]2017YesUSA2Medical and surgical ICUsConstruct validity: frailty markers, frailty assessment and demographic correlates of frailty. Predictive validity: new disability and deathYesLe Maguet \[[@CR30]\]2014YesFrance4Mixed medical-surgical ICUPredictive validity: mortalityYesPugh \[[@CR31]\]2017No - research letter onlyUK1Mixed medical-surgical ICUInter-rater reliability of frailty assessmentYesTable 2Patient characteristicsStudyNumber of patientsSex (% male)Age restrictionAge in years, mean (+/- SD) or median (IQR)Operative statusProportion receiving invasive ventilationBagshaw \[[@CR26]--[@CR28]\]42161%50 Years and older^a^67 +/-10Post-operative: 34%86%Brummel \[[@CR29]\]104060%18 Years and older62 (53- 72)Post-operative: 16%88%Fisher \[[@CR32]\]34859%^b^18 Years and older60 (+/-17)Post-operative: 53%Not reportedFlaatten \[[@CR36]\]502152%80 Years and older84 (81- 86)Post-operative: 27%51%Heyland \[[@CR33], [@CR34]\]61055%80 Years and older84 (+/- 3)Post-operative: 39%72%Hope \[[@CR35]\]9556%None57 (+/- 18)Post-operative: 6%56%Le Maguet \[[@CR30]\]19665%65 Years and older75 (+/- 6)Post-operative: 65%88%Pugh \[[@CR31]\]3060%16 Years and older67 (+/- 14)Not collectedNot collected^a^Bagshaw (2016) focused on patients aged 50--64.9 years of age \[[@CR28]\]^b^Among patients undergoing clinical frailty scale assessment

In the majority of studies, the main aim was assessment of predictive validity (e.g. in terms of mortality, length of stay, disability, and health-related quality of life). In only one study was the primary intention to evaluate reliability of frailty assessment \[[@CR31]\], and in only one other was the feasibility of frailty assessment an explicit outcome \[[@CR32]\]. However, each of the other six studies included presented data sufficient to enable evaluation of the feasibility of frailty assessment in critical care.

Risk of bias within studies {#Sec12}
---------------------------

Six studies were considered at unclear overall risk of bias \[[@CR26]--[@CR31], [@CR35], [@CR36]\] and two studies were considered at low overall risk of bias \[[@CR32]--[@CR34]\] (Table [3](#Tab3){ref-type="table"}). Regarding selection bias, the Bagshaw, Fisher, and Heyland reports were considered at low risk, since potential differences between patients recruited and not recruited had been explored \[[@CR26]--[@CR28], [@CR32]--[@CR34]\]. In terms of comparability, the Fisher, Heyland, and Hope reports were considered at low risk of bias, since in these studies the proxy contribution to assessment of frailty was quantified \[[@CR32]--[@CR35]\]. Only one study explored the reliability of frailty assessment, for which outcome bias was considered low risk due to the adoption of blinded assessment \[[@CR31]\]. No studies were considered high risk and sensitivity analysis was therefore not performed.Table 3Risk of bias in included studies, with regards to feasibility and reliabilityStudyRisk of biasNotesSelection bias^a^Comparability^b^Outcome^c^Overall riskBagshaw \[[@CR26]--[@CR28]\]LowUnclearn/aUnclearNo statistically significant differences between study participants and non-enrolled. Involvement of proxy vs. patient not specified.Brummel \[[@CR29]\]UnclearUnclearn/aUnclearReasons for non-enrolment described, but potential differences between such patients not explored. Timing of frailty assessment described, but data regarding proxy involvement not collected.Fisher \[[@CR32]\]LowLown/aLowReasons for not evaluating frailty not recorded, though there is comparison of evaluated vs. non-evaluated patients.Flaatten \[[@CR36]\]UnclearUnclearn/aUnclearNumbers of potentially eligible patients not enrolled and reasons for non-enrolment not collated. Proxy data not collected.Heyland \[[@CR33], [@CR34]\]LowLown/aLowCharacteristics of study cohort were similar to unselected hospital cohort.Hope \[[@CR35]\]UnclearLown/aUnclearReasons for non-enrolment described, but potential differences between such patients and those enrolled not studied. Proxy involvement described.Le Maguet \[[@CR30]\]UnclearUnclearn/aUnclearReasons for non-inclusion partially described. Potential differences between included and excluded patients not investigated.Pugh \[[@CR31]\]UnclearUnclearLowUnclearReasons for non-enrolment not recorded nor details regarding proxy involvement. Interval between assessments not recorded. Assessors were blinded to other assessments.*n/a* not analysed^a^Study group truly representative of critically ill population, reasons for non-inclusion are described, differences between included and excluded eligible patients analysed^b^Description of proxy involvement, timing of assessments, interval between assessments, staff involved in assessments^c^Investigating reliability of assessment, assessments performed independently and blindly analysed

Assessment of frailty {#Sec13}
---------------------

All studies evaluated frailty using a clinical frailty scale (CFS) \[[@CR10]\]; six studies used a 9-point scale \[[@CR26]--[@CR28], [@CR30], [@CR31], [@CR35], [@CR36]\] (see Fig. [2](#Fig2){ref-type="fig"}) and two a 7-point scale \[[@CR29], [@CR33], [@CR34]\]. Additional scoring systems were used in three studies \[[@CR30], [@CR33]--[@CR35]\]. Two studies utilised a frailty phenotype (FP) assessment, identifying frailty on the basis of the following domains: shrinking, weakness, slowness, low-level physical activity, and self-reported exhaustion \[[@CR11]\], but modified for use in the critically ill (see Table [4](#Tab4){ref-type="table"}) \[[@CR30], [@CR35]\]. Furthermore, Hope and colleagues supplemented these FP domains with questions relating to cognitive and to sensory impairment \[[@CR35]\]. One study utilised a frailty index based on a 43-item comprehensive geriatric assessment (CGA) \[[@CR33], [@CR34]\].Fig. 2Clinical frailty scale \[[@CR10]\]Table 4Assessment of frailty according to frailty phenotypeFrailty domainFried \[[@CR11]\]Le Maguet \[[@CR30]\]Hope \[[@CR35]\]ShrinkingUnintentional (not due to dieting or exercise) weight loss 10 lbs (4.5 kg) or more than 5% of body weight in the prior yearUnintentional (not due to dieting or exercise) weight loss ≥ 4.5 kg or more than 5% of body weight in the prior yearReported weight loss and BMI \< 24 or ≥ 5% weight lossWeaknessHand-grip strength measured by dynamometer (stratified by gender and body mass index)Difficulty rising from a chairUnable to rise from a chair without using armsSlownessTime to walk 15 feet (stratified by gender and height)Slowed walking speed (during the last 6 months, with difficulties walking and with aid) and/or the occurrence of fall(s)Falls or need for assistance with mobility inside or outside the home in the past yearLow physical activityUse of Minnesota Leisure Time Activity Questionnaire to calculate\
kilocalories expended per weekDiscontinued daily leisure activities such as walking or gardening and/or discontinued some sport activity per weekUnable to climb flight of stairs or undertake moderate activity, e.g. pushing a vacuum cleaner or bowlingExhaustionFeeling that everything the patient does is an effort and/or the feeling that he/she could not get going, and how often in the last 3 months he/she felt this wayFeeling that everything the patient does is an effort and/or the feeling that he/she could not get going, and how often in the last 3 months he/she felt this wayFeeling that everything the patient does is an effort and/or the feeling that he could not get going, in past 4 weeks; number of times he/she had a lot of energy in past 4 weeksCognitive ImpairmentMemory Impairment Screen, or modified version of the Short-Form Informant Questionnaire on Cognitive Decline in the ElderlySensory ImpairmentProblems in daily life because of poor vision or impaired hearing in last yearFrailty identified on the basis of two or three or more elements \[[@CR35]\], or three or more elements \[[@CR11], [@CR30]\]

Timing of frailty assessment was available in seven studies. Frailty was assessed at critical care admission \[[@CR30]\], within the first 24 hours \[[@CR32], [@CR36]\] or first 72 hours of critical care admission \[[@CR29], [@CR33]--[@CR35]\] (Table [5](#Tab5){ref-type="table"}). A variety of reference points for assessment were adopted: the subject\'s condition before ICU admission \[[@CR32]\], before hospital admission \[[@CR26]--[@CR28]\], before onset of critical illness \[[@CR29]\], before acute illness and hospital admission \[[@CR36]\], 2 weeks before hospital admission \[[@CR31], [@CR33], [@CR34]\] or one month before hospital admission \[[@CR30]\].Table 5Issues relating to frailty assessmentStudyFrailty assessment toolTiming of frailty assessmentReference point for frailty assessmentInterval between assessmentsBagshaw \[[@CR26]--[@CR28]\]CFSNot recordedImmediately before hospitalisationNot applicableBrummel \[[@CR29]\]CFSWithin 72 hours of ICU admissionPrior to critical illnessNot applicableFisher \[[@CR32]\]CFSWithin first 24 hours of ICU admission (for next-of-kin)Pre-ICU admissionNot applicableFlaatten \[[@CR36]\]CFSWithin first 24 hours of ICU admissionBefore acute illness and hospital admissionNot applicableHeyland \[[@CR33], [@CR34]\]CFS,\
FIAt 48 − 72 hours after ICU admissionAt 2 weeks pre-hospital admissionNot recordedHope \[[@CR35]\]CFS,\
FPWithin 72 hours of ICU admissionCFS: not specified FP: variable, depending on elementWithin 24 hoursLe Maguet \[[@CR30]\]CFS,\
FPAt ICU admissionAt 1 month pre-hospital admissionNot recordedPugh \[[@CR31]\]CFSNot recordedAt 2 weeks pre- hospital admissionNot recorded*FP* frailty phenotype, *CFS* clinical frailty score, *n/a* not analysed

Feasibility of frailty assessment {#Sec14}
---------------------------------

A member of the research team assessed frailty in five studies \[[@CR26]--[@CR29], [@CR31], [@CR33]--[@CR35]\]; in three studies critical care doctors with clinical rather than research responsibilities assessed frailty using a CFS \[[@CR31], [@CR35]\] or a CFS and FP \[[@CR30]\]; in one study critical care nurses and doctors assessed frailty using a CFS \[[@CR36]\], and in one study it was the nurse-in-charge or next-of-kin (with nurse guidance) who assigned a CFS score \[[@CR32]\] (Table [6](#Tab6){ref-type="table"}). Researchers received specific training to familiarise themselves with the study and assessment tool(s) in four studies \[[@CR29], [@CR31], [@CR33]--[@CR35]\]; critical care nurses received CFS training in the form of a series of lectures in one study \[[@CR32]\]. In the remaining three studies, training clinical staff to use CFS took place in a staff meeting \[[@CR30]\], at the bedside \[[@CR31], [@CR35]\] or was deemed not to need particular training \"since the description combined with illustration is intuitive\" \[[@CR36]\]. The times required for training and to perform assessments were for the most part not captured during the course of included studies (Table [6](#Tab6){ref-type="table"}).Table 6Feasibility of frailty assessmentStudyFrailty assessor(s)Training requiredTime required for assessmentPatient participationProxy involvementNeither patient nor proxy involvedPercent screened patients^a^ excluded due to lack of proxyBagshaw \[[@CR26]--[@CR28]\]Research coordinatorNot describedNot recordedNot recordedNot recordedNilNot recordedBrummel \[[@CR29]\]Study personnelTrained by geriatrician during 2-day trial start upNot recordedNot recordedNot recordedNil31% because of lack of proxyFisher \[[@CR32]\]Next-of-kin (NOK), nurse in charge if NOK unavailable in first 24 hoursSeries of lectures for nurses; bedside introduction with standardised script for NOKNot recordedNone73%27%NilFlaatten \[[@CR36]\]Critical care staffNoneNot recordedNot recordedNot recordedNot recorded\< 0.2% because of lack of proxy^b^Heyland \[[@CR33], [@CR34]\]Research coordinatorEmbedded within start-up trainingNot recordedNone100% (excluded if no family member available)Nil45% missed caregiverHope \[[@CR35]\]CFS: critical care doctor FP: research teamBedside explanation (CFS)\
Specific training in use of questionnaire and frailty construct (FP)Not recorded42%58%Nil12% because of lack of proxyLe Maguet \[[@CR30]\]Critical care staffStaff meetingNot recorded39%69%Nil20% because of lack of proxyPugh \[[@CR31]\]Medical student investigators, critical care doctorTraining for medical students, bedside explanation for doctors.Not recordedNot recordedNot recordedNilNot recorded*CFS* clinical frailty scale, *FP* frailty phenotype^a^Otherwise meeting study enrolment criteria^b^Not specified by authors but 99.8% included patients have frailty assessment

Two studies excluded patient involvement in frailty assessment in their methodology \[[@CR32]--[@CR34]\]. Of these, availability of a family member was a requirement for study enrolment in Heyland\'s study \[[@CR33], [@CR34]\]. In Fisher\'s study, the CFS assessment was expected to be made by the next-of-kin under the guidance of the bedside nurse, using a standardised introduction; however, CFS assessment was made by the nurse-in-charge if the next-of-kin was unavailable in the first 24 hours of critical care admission \[[@CR32]\]. The researchers reported that when no assessment had been made, patients were more likely to have been post-operative or to have had a shorter critical care stay. In Le Maguet \[[@CR30]\], 31% of patients were able to interact with an interviewer to enable assessment, and in Hope \[[@CR35]\], 42% patients contributed to frailty assessment. In the other three studies, patient participation was not recorded.

Where recorded, a proxy was involved in 58% \[[@CR35]\], 69% \[[@CR30]\], 73% \[[@CR32]\] and 100% \[[@CR33], [@CR34]\] of frailty assessments (Table [6](#Tab6){ref-type="table"}). Fisher found that it was not possible to approach the next of kin for involvement in assessment in 27% cases within the first 24 hours of critical care admission; however, since the nurse in charge could make a CFS assessment on the basis of medical records, this did not prohibit frailty assessment \[[@CR32]\]. Flaatten did not specify the contribution of patient or proxy to assessment, but noted that CFS assessment was achieved in 99.8% of cases included \[[@CR36]\]. Hope noted that in some instances surrogates were unable to answer questions relating to an assessment of frailty according to FP assessment, for example, according to domains of weight loss (5% of cases) or loss of energy (3% of cases) \[[@CR35]\]. Le Maguet also found that \"several components of the FP score, notably those that evaluate performance, were difficult to explore in ICU patients\" \[[@CR30]\]. Overall, screened patients excluded from enrolment due to lack of proxy availability ranged from 0 to 45% in five studies \[[@CR29], [@CR30], [@CR32]--[@CR35]\]: the highest exclusion rate was in Heyland\'s study, in which frailty was assessed according to a 43-item CGA and a CFS, and in which family involvement was an absolute requirement for enrolment \[[@CR33], [@CR34]\].

Reliability of frailty assessment {#Sec15}
---------------------------------

Reliability of frailty assessment was assessed in only one study, which evaluated the inter-rater reliability of frailty assessment using a CFS as a comparison between two groups, a group of medical students and a group of critical care doctors. Linear weighted kappa was 0.64 (95% confidence intervals 0.40 to 0.87, *p* \< 0.0001), suggesting good agreement. However, this was a small (*n* = 30), single-centre study comparing only two groups of assessors (medical students and critical care doctors, excluding other members of the clinical team), and which did not make reference to the relative contributions of the critical care patient or a proxy.

Discussion {#Sec16}
==========

In assessing the feasibility of frailty assessment, we have made a distinction between those primarily involved in clinical and in research roles in view of anticipated differences in training and time available to apply assessment tools. Though not well-described, clinical staff for the most part appear to have received relatively little training with regards the application of frailty assessment tools compared with those described as \"research coordinator\" or \"study personnel.\" Despite this, the high proportion of patients among included studies undergoing frailty assessment using the judgement-based CFS by clinical staff is likely to reflect its simplicity and ease of application \[[@CR36]\]. Indeed CFS assessment seemed achievable even in the absence of family contact \[[@CR32]\].

With regard to other assessment methods, the two studies utilising FP assessment reported difficulties with some components of FP assessment, despite making adaptations for a critically ill population. However, FP assessment was used by both clinical \[[@CR30]\] and research staff \[[@CR35]\]. The early phase of critical illness typically precludes elements of frailty assessment, which require demonstration rather than description (e.g. grip strength and gait speed), though such assessment appears feasible for ICU survivors much nearer to hospital discharge \[[@CR37]\]. The consequences of such modifications for frailty classification and predictive validity in this population are uncertain \[[@CR38]\]. FI-CGA was used to assess frailty in only one study, and although the time required to administer the 43-item questionnaire to a family member by the research coordinator was not recorded, it is unclear whether this would be too time-consuming to be feasibly delivered by a critical care team on a routine basis. Recent research has reported the development and validation of a 36-item electronic frailty index (eFI) using routinely available electronic medical record (EMR) data \[[@CR39]\], which may be an attractive approach for critical care but requires further validation in this context.

A high proportion of enrolled patients were invasively ventilated and only a minority able to participate directly in frailty assessment. There is clearly a heavy reliance on proxy input for frailty assessment in this population, particularly when detailed information is required \[[@CR32]--[@CR34]\], and Heyland\'s study illustrates the difficulty of coordinating the availability of assessor and an appropriate family member when FI-CGA assessment is made by a limited number of trained individuals.

A dependence on proxy input is also highly relevant when considering the reliability of frailty assessment in the critically ill. We identified only one small clinical study that investigated the inter-rater reliability of CFS assessment between a group of critical care doctors and a group of medical students \[[@CR31]\]. Although there was a good level of agreement, the study did not capture the relative contributions of the patient or their proxies to frailty assessment. Furthermore, we found no study that had attempted to compare assessment of frailty between clinical staff and critically ill patients or their relatives, or to evaluate the influence of clinical background, seniority, and training on frailty assessment. When carefully selected, other investigators have identified a high level of agreement between subject and proxy in terms of functional status after critical illness \[[@CR40]\]. However, the retrospective nature of frailty assessment (in the manner identified in included studies) makes it prone to recall bias, particularly in the context of acute and sub-acute chronic illness \[[@CR14], [@CR41]\]. Furthermore, subjective elements (e.g. \"exhaustion\" \[[@CR30], [@CR35]\]) rather than observable criteria may be especially susceptible to differences between proxy and subject ratings \[[@CR42], [@CR43]\]. The reliability of frailty assessment by clinicians is an important issue; in other settings, escalation decision-making following emergency admission may be made on the basis of a perception of baseline cognitive and functional status, which at best only modestly correlates with that of patient or relative \[[@CR44]\].

There are several strengths to this review. We prospectively registered our review protocol and have followed rigorous methodology to identify, evaluate, and summarise the current evidence on feasibility and reliability of frailty assessments in the critically ill. However, we recognise some limitations. Assessment of the feasibility and reliability of frailty assessment was the intended outcome of only two of the eight studies included, and this is reflected in absent or incomplete data on factors that may have contributed to inclusion or exclusion of patients (e.g. to \"missed caregiver\"), the background of assessor, the training and time taken to perform assessment, background of any proxies, and the relative involvement of patient and proxy in the assessments. As a consequence, for the purposes of evaluating feasibility and/or reliability of frailty assessment in the critically ill, only two studies were considered at low overall risk of bias.

However, our review has a number of implications for clinical practice. We found evidence that frailty assessment can feasibly be performed by different clinical members of the critical care team (whether physician, nurse or medical student), that patient participation in such assessment will be achieved in a minority of cases, and that a qualifying proxy is usually required. We found limited data indicating that frailty can be reliably assessed by clinicians in the critical care setting. Given the challenges inherent in frailty assessment in critical illness, more research is needed regarding the reliability of frailty assessment tools in critical care before frailty assessment can be used to aid clinical decision-making and/or trigger interventions.

This review highlights areas for future research. Frailty is a dynamic state, and frailty assessment in the context of variations in health trajectories prior to critical illness needs exploration. Further study is required to compare the relative performance of frailty assessment tools in critical care, taking into account the reference point for assessment, the background and training of the assessor(s), the capacity of the patient, and the relationship between patient and proxy. In particular, the relative performance of frailty assessment using routinely captured data versus bedside frailty assessment should be evaluated in this population. Last, a clearer understanding of the training required and the time taken to make an assessment of frailty needs to be considered in the context of the potential benefits of making that assessment.

Conclusions {#Sec17}
===========

This review has found little evidence of reliability and only limited evidence on the feasibility of frailty assessment in the critically ill. CFS was the most widely applied assessment tool by clinical staff, conventional FP assessment required modification for general application in critical care, and FI-based assessment may be difficult to deliver by the critical care team on a routine basis. Additional research is required to investigate the resource implications of routine use of frailty tools, to evaluate reliability when used by a range of clinical personnel, to investigate the use of routinely available EMR data for identifying frailty, and to study reliability in the presence or absence of clinical proxies before recommending widespread application in routine critical care practice.
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